Top Markets
Coin of the day
Igene Biotechnology, Inc. Igene Biotechnology, Inc.

Igene Biotechnology, Inc.

IGNE
Rank in Stocks #41582
Igene Biotechnology, Inc. is dedicated to the discovery, development,... Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Share Price
$0.00001
Last synced: 2026-08-11
Market Cap
$15.65K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Igene Biotechnology, Inc. (IGNE)
Revenue for Igene Biotechnology, Inc. (IGNE)
Revenue in Aug 2026 TTM: 0
According to Igene Biotechnology, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Igene Biotechnology, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors